Enhanced Telemedicine for Type 2 Diabetes
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Pittsburgh
Must be taking: Insulin
Disqualifiers: Age over 80, Dementia, ESRD, Malignancy, others
No Placebo Group
Trial Summary
What is the purpose of this trial?The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is:
Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible?
Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes.
Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current medications, especially since the trial involves managing diabetes with insulin.
What data supports the effectiveness of the treatment Enhanced Telemedicine for Type 2 Diabetes?
Research shows that telemedicine can help improve blood sugar control in people with diabetes by allowing real-time monitoring and management. Programs like Project ECHO have successfully improved health outcomes for patients with complex diabetes, especially in underserved areas.
12345How is the Enhanced Telemedicine treatment for Type 2 Diabetes different from other treatments?
Enhanced Telemedicine for Type 2 Diabetes is unique because it uses technology to provide real-time support and data sharing between patients and healthcare providers, which can improve glucose control and reduce the need for frequent in-person visits. This approach is particularly beneficial for those who have limited access to traditional healthcare services.
15678Eligibility Criteria
This trial is for adults with type 2 diabetes who use insulin and have multiple chronic conditions. Participants will engage in telemedicine visits over about 6 months. They must be willing to complete surveys during their care visits.Inclusion Criteria
I have been diagnosed with type 2 diabetes.
Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits
I am 18 years old or older.
+4 more
Exclusion Criteria
Visit with an endocrinologist in the prior 3 years
I am over 80 years old.
Currently enrolled in another diabetes management intervention study
+5 more
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Baseline
Baseline survey measures and clinical data collection via chart review
1-2 weeks
1 visit (virtual)
Treatment
Participants receive enhanced telemedicine intervention or usual care for type 2 diabetes
6 months
2-3 visits (virtual) with additional individualized visits
Follow-up
Participants are monitored for safety and effectiveness after treatment
4 weeks
Participant Groups
The study compares usual telemedicine endocrinology care with an enhanced version for managing type 2 diabetes. The enhanced program includes pre-visit calls, education, support, and post-visit follow-ups to see if it improves patient satisfaction or clinical outcomes.
2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Telemedicine CareExperimental Treatment1 Intervention
Specialty care for type 2 diabetes delivered via telemedicine by an endocrinologist, with additional multidisciplinary support from the diabetes care team.
Group II: Usual CareActive Control1 Intervention
Specialty care for type 2 diabetes delivered via telemedicine by an endocrinologist following usual clinical care protocols.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of PittsburghPittsburgh, PA
Loading ...
Who Is Running the Clinical Trial?
University of PittsburghLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
References
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial. [2022]Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate if a web-based telemedicine system (the Glucoonline® system) is effective to improve glucose control in insulin-treated patients with type 1 and type 2 diabetes, as compared to standard of care.
Taking Telemedicine to the Next Level in Diabetes Population Management: a Review of the Endo ECHO Model. [2018]Worldwide increases in diabetes prevalence in the face of limited medical resources have prompted international interest in innovative healthcare delivery models. Project ECHO (Extension for Community Healthcare Outcomes) is a "telementoring" program which has been shown to increase capacity for complex disease management in medically underserved regions. In contrast to a traditional telemedicine model which might connect a specialist with one patient, the ECHO model allows for multiple patients to benefit simultaneously by building new expertise. We recently applied the ECHO model to improve health outcomes of patients with complex diabetes (Endo ECHO) living in rural New Mexico. We describe the design of the Endo ECHO intervention and a 4-year, prospective program evaluation assessing health outcomes, utilization patterns, and cost-effectiveness. The Endo ECHO evaluation will demonstrate whether and to what extent this intervention improves outcomes for patients with complex diabetes living in rural New Mexico, and will serve as proof-of-concept for academic medical centers wishing to replicate the model in underserved regions around the world.
Detection and remediation of medically urgent situations using telemedicine case management for older patients with diabetes mellitus. [2021]Detection and response to medically urgent situations in patients with diabetes mellitus can improve the process and outcomes of care and potentially decrease morbidity and mortality. We examined the detection and remediation of medically urgent situations among older patients receiving telemedicine case management for diabetes.
A pilot study of diabetes education via telemedicine in a rural underserved community--opportunities and challenges: a continuous quality improvement process. [2022]Telemedicine technology may offer an avenue to implement diabetes self-management education (DSME) for people with diabetes in underserved rural communities. The continuous quality improvement process was used to identify the problem, collect and analyze data, and develop and implement a DSME program via telemedicine (DSME-T) in an underserved rural community.
Improving Glycemic Control With a Standardized Text-Message and Phone-Based Intervention: A Community Implementation. [2020]Type II diabetes mellitus (T2DM) presents a major disease burden in the United States. Outpatient glycemic control among patients with T2DM remains difficult. Telemedicine shows great potential as an adjunct therapy to aid in glycemic control in real-world settings.
Implementation of telehealth support for patients with type 2 diabetes using insulin treatment: an exploratory study. [2019]Initiating and adjusting insulin treatment for people with type 2 diabetes (T2D) requires frequent clinician contacts both face-to-face and by telephone. We explored the use of a telehealth system to offer additional support to these patients.
Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial. [2023]Medically underserved people with type 2 diabetes mellitus face limited access to group-based diabetes care, placing them at risk for poor disease control and complications. Immersive technology and telemedicine solutions could bridge this gap.
Low-intensity self-management intervention for persons with type 2 diabetes using a mobile phone-based diabetes diary, with and without health counseling and motivational interviewing: protocol for a randomized controlled trial. [2022]The present study protocol is designed to cover the Norwegian part of the European Union Collaborative Project-REgioNs of Europe WorkINg together for HEALTH (RENEWING HEALTH). Self-management support is an important element of care for persons with type 2 diabetes (T2D) for achieving metabolic control and positive lifestyle changes. Telemedicine (TM) with or without health counseling may become an important technological aid for self-management and may provide a user-centered model of care. In spite of many earlier studies on TM, there remains a lack of consensus in research findings about the effect of TM interventions.